探案:惶恐不安的反复咳血和支气管腔内“肿物”

2018-01-10 李冰、马玉燕、金文婷 SIFIC感染官微

2015年7月出现咳嗽咳痰,痰白色,Tmax 37.7℃,查WBC 9.9*10^9/L,N 69%,CRP 137mg/L,胸部CT见右肺下叶感染灶,予阿莫西林+左氧氟沙星治疗10天症状好转。

一、病史简介

男性,52岁,浙江人,2017-07-19入中山医院感染病科

主诉:反复咳嗽、咳痰、咯血2年。

现病史:

2015年7月出现咳嗽咳痰,痰白色,Tmax 37.7℃,查WBC 9.9*10^9/L,N 69%,CRP 137mg/L,胸部CT见右肺下叶感染灶,予阿莫西林+左氧氟沙星治疗10天症状好转。

2015年12月咯血1次,量约5ml,呈暗红色,无发热,未予特殊处理。之后常有咳嗽咳白痰,未予重视。

2017年6月再次咯血,每天数口,为鲜红色,无发热、呼吸困难和胸痛。胸部CT示右下肺后基底段支气管扩张伴黏液栓形成可能,左侧胸膜增厚。当地医院予止血治疗后未再咯血。

2017年7月初,患者仍有咳嗽咳少量白痰,无咯血、发热,来我院门诊,随访胸部CT见右肺后基底段支气管腔阻塞,病灶较外院稍进展。为进一步诊治,收住感染病科。

既往史及个人史:否认高血压糖尿病。2017年3月因冠心病冠脉置入支架1枚,后规律口服阿司匹林100mg qd(因咯血于2017-7-18起停用)和氯吡格雷75mg qd。吸烟20余年,平均1包/天,否认饮酒。否认呛咳史、生食史及禽类接触史。



二、入院检查及诊疗(2017-7-19)

体格检查:

T 37℃,P 72bpm,R 20次/分,BP 113/86mmHg

双肺呼吸音清,未及明显啰音

实验室检查:

血常规:Hb 108g/L;WBC 4.69X10^9/L;N 58.5%;L 1.3%;E 5.5%

炎症标志物:CRP 7.3mg/L;ESR 42mm/H;PCT 0.04ng/mL

肺炎支原体抗体、呼吸道病原九联检、G试验:(-)

T-SPOT A/B:2/4;血隐球菌荚膜抗原:(-)

痰涂片+普通细菌培养*1次:(-)

免疫球蛋白:IgE 60 IU/mL;IgG 15.9g/L;IgG4 1.2g/L

自身抗体:ANA 1:100,余均阴性

肿瘤标志物:均正常

生化:ALT/AST 11/15U/L;Alb 41g/L;Cr 93μmol/l

血气分析(不吸氧):pH 7.42;Pa02 81.0mmHg;PaCO2 40.0mmHg

辅助检查:

心电图:窦性心动过缓(HR=58)

心超:主动脉窦部稍增宽,左室射血分数70%

腹盆增强CT:未见异常

三、临床分析

病史特点:患者中年男性,慢性病程,主要表现为反复咳嗽、咳白痰及少量咯血。2年前起病时胸部CT见右肺下叶实变影,抗感染治疗有效,但之后症状仍有反复,迁延不愈,随访影像示右下叶后基底段支气管管腔阻塞可能,诊断和鉴别诊断考虑如下:

支气管肺癌:患者中年男性,有长期吸烟史,慢性咳嗽咳痰且反复咯血,胸部CT提示支气管腔内病变,支气管肺癌首先考虑。但病程2年,右下病灶进展不明显,入院查肿瘤标志物阴性,为不支持点,可行气管镜检查及病理组织学明确病变性质。

过敏性支气管肺曲霉菌病(ABPA):患者咳嗽咳痰迁延不愈,CT提示见可疑痰栓,ABPA需要考虑,但患者外周血嗜酸性粒细胞比例及IgE水平正常,门诊与住院查痰真菌培养均阴性,且胸部CT未见到ABPA典型的“指套征”或向心性支气管扩张。

肺曲霉感染:对于长时间反复少量痰血,胸部CT表现的不规则肺结节,需要考虑肺曲霉感染可能,确诊则有赖于肺活检标本的组织病理检查。临床上有不少病例是手术切除的病理检查才得以确诊。

肺或支气管结核:反复咳嗽咯血,支气管腔可疑狭窄或阻塞,肺结核甚至支气管内膜结核也需要考虑。但患者仅起病时有低热,后未再发热,亦无乏力消瘦及盗汗等结核中毒症状,入院查痰涂片抗酸染色及T-SPOT均为阴性,而且病程两年CT上未见纤维索条和斑点增殖病灶,为不支持点,进一步明确或排除本病,则有赖于气管镜检查下的组织病理和微生物检验。

支气管异物:异物吸入亦可造成支气管管腔阻塞而引起反复阻塞性肺炎,迁延不愈,反复追问患者否认病前有醉酒及呛咳史,CT上未见支气管腔内高密度骨性异物影,支气管镜检查可明确诊断。

四、进一步检查、诊治过程和治疗反应

第一次入院(2017.7.19-7.27)

7-20 胸部CT显示右支气管腔内病变可能,肿瘤不能除外,需要进行支气管镜检查。心内科会诊考虑冠脉支架植入后仅4月,停用氯吡格雷后出现支架内血栓风险大,不建议停用。与家属及患者沟通,支气管镜检查必要性和未停抗血小板药物下支气管镜活检的风险,家属表示接受支气管镜检查但不做组织活检。

7-21 支气管镜检查:右下叶后基底段管腔内见肉芽组织增生伴粘膜糜烂坏死,未行活检。局部支气管肺泡灌洗,BALs送微生物学检查。余支气管管腔通畅。

7-22 予左氧氟沙星0.6g ivgtt qd。

7-25 BALs二代测序结果:检测到多种厌氧菌,未发现特殊病原微生物。BALs常规检验:细菌、真菌涂片及培养(-),涂片找抗酸杆菌(-)。

7-27 咳嗽咳痰稍好转,炎症指标下降(CRP 7.3→2.8mg/L,ESR42→24mm/h),遂出院。带药:口服左氧氟沙星0.4g qd*6d。并嘱密切随访胸部CT。





第二次入院(2017.10.23-11.8)

10-23因仍有咳嗽咳痰,要求支气管镜检查和活检,以明确右下支气管腔内病灶性质而再次入住我院感染病科。患者诉上次出院后曾有少量咯血1次。胸部CT见右肺后基底段病灶较前稍好转。

10-25心内科会诊,可停氯吡格雷,改低分子肝素4100IU qd皮下注射。10-30停低分子肝素。

10-31行第二次支气管镜:右下叶后基底段支气管开口处可见一新生物,完全堵塞管腔,于该处行活检并刷检。余管腔通畅。灌洗液、组织、咳出物细菌、真菌涂片+培养均阴性,涂片找抗酸杆菌阴性,分枝杆菌培养均阴性(12-13回报);灌洗液外送基因二代测序检查未见明确致病微生物。

11-1患者支气管镜术后无明显咯血,恢复氯吡格雷口服。

11-1支气管镜刷检脱落细胞检查未见恶性肿瘤细胞;病理提示浆细胞为主的炎性病变,与病理科医生联系,考虑肿瘤性、肉芽肿性病变依据不足,IgG4相关疾病不能除外,建议查血清IgG4。

11-3复测血清IgG4 1.1g/L,正常。

11-8反复检测未见致病微生物,抗感染治疗后炎症标志物正常,活检提示炎症性病变,但考虑活检部位表浅,仍不除外肿瘤性病变可能,予出院随访,必要时外科手术明确病灶性质。





第三次入院(2017.12.15-12.21)

12-15入我院胸外科。术前PET/CT示右肺下叶内侧基底段见沿支气管走行软组织密度影,最大SUV值约3.4;右肺下叶内侧基底段及后基底段支气管扩张伴后基底段膨胀不全。

12-18行胸腔镜下右肺下叶切除术,术中探查:胸腔无积液及结节,取部分手术标本送微生物培养及基因二代测序;病理提示支气管异物(植物组织,疑似辣椒)。

12-21术后恢复顺利出院。











五、最后诊断与诊断依据

最后诊断:

右下肺支气管异物(辣椒可能)伴炎症

冠状动脉粥样硬化性心脏病(PCI术后)

诊断依据:

患者中年男性,病程2年,主要表现为反复咳嗽、咳白痰及少量咯血,发热不明显。胸部CT示右下叶后基底段病灶,最初病灶较大呈炎症渗出和实变,之后表现为右下叶后基底段支气管腔阻塞伴周围不规则结节影。第一次支气管镜检查,见内基底段支气管腔内肉芽组织增生伴粘膜糜烂坏死;3个月后再次支气管镜检查,显示管腔完全被新生物堵塞。但局部活检提示为“浆细胞为主的炎性病变,肿瘤证据不足”。之后行胸腔镜下右肺下叶切除术,病理证实支气管内有异物组织(疑似辣椒),未见肿瘤依据。据此,“气道异物伴炎症”诊断可建立。切除的病变组织培养出龋齿放线菌以及mNGS检出多种厌氧菌,可考虑局部阻塞后导致的继发感染,为口腔菌群引起的混合感染。

六、经验与体会

气道异物没有及时发现和取出,继而引起阻塞性肺炎,通常认为是少见现象。但我院感染病科在过去半年内,在疑难肺炎中竟然发现3例气道异物,此值得引起重视,在疑难复杂的肺炎中,气道异物也需要经常考虑的一项原因,尤其对于老年人。

气道异物多为碎骨、豆子、果核等,本例异物疑似辣椒,临床甚为罕见。由于此异物密度低,多次胸部CT检查,均未能发现。文献报道,气道异物的胸部影像学经常缺乏特异性表现,能于管腔中直接发现异物的比例仅25%左右,当胸部CT肺窗发现管腔狭窄时需对比纵隔窗观察管腔内有无异常密度影。另一方面,若未发现管腔异常,但有局部阻塞性肺炎、肺气肿、肺不张或支气管管扩张等表现,也需要警惕是否为气道异物的间接征象,但仅凭此,无法与支气管肿瘤相鉴别。

支气管镜检查对气道异物的确诊和治疗有着重要价值,通过支气管镜可直接观察管腔,对性质不明的管腔内肿物活检,若明确气道异物也可在支气管镜直视下取出。但对于滞留时间较长的异物,周围粘膜形成大量肉芽组织,对明确诊断或镜下摘取,显得十分困难。对少数疑难病例,可能需要外科手术干预。

异物可与口腔分泌物同时吸入,异物表面携带的微生物和口腔菌群进入气道后可继发肺部感染。本例患者肺组织匀浆中培养出的龋齿放线菌和mNGS检出的多种口腔厌氧菌,提示气道异物继发的肺部感染,抗感染治疗药物选择,通常需覆盖口腔菌群。

原始出处:

[1].SamareiR, et al. Survey of Foreign Body Aspiration in Airways and Lungs. GlobalJournal of Health Science, 2014, 6(7): 130-135.

[2]Lin LJ, et al. The clinical features of foreign body aspiration into the lowerairway in geriatric patients. Clinical Interventions in Aging, 2014, 9:1613–1618.

[3]GruberM, et al. The bacterial species associated with aspirated foreign bodies inchildren. Auris Nasus Larynx(2017),.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1892130, encodeId=b9c71892130f5, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Fri Sep 21 18:45:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989752, encodeId=f6601989e528a, content=<a href='/topic/show?id=9f233e69666' target=_blank style='color:#2F92EE;'>#反复咳血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37696, encryptionId=9f233e69666, topicName=反复咳血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Oct 20 12:45:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680065, encodeId=c617168006573, content=<a href='/topic/show?id=67e282e66d8' target=_blank style='color:#2F92EE;'>#肿物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82766, encryptionId=67e282e66d8, topicName=肿物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=179b27837900, createdName=LSJ120, createdTime=Mon May 14 11:45:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278304, encodeId=1b682e8304fa, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jan 14 06:46:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277989, encodeId=49a12e7989dc, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Sat Jan 13 05:37:33 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277485, encodeId=24ae2e748594, content=受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/11/843340fb4682f03b12c0770c09229692.jpg, createdBy=47aa2244654, createdName=121503aam61暂无昵称, createdTime=Thu Jan 11 09:29:53 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277461, encodeId=fcd32e746156, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Jan 11 08:27:55 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277413, encodeId=0e512e741313, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Jan 11 06:54:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277395, encodeId=f1822e739514, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Jan 11 06:42:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277378, encodeId=e4482e737887, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Jan 11 05:21:04 CST 2018, time=2018-01-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1892130, encodeId=b9c71892130f5, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Fri Sep 21 18:45:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989752, encodeId=f6601989e528a, content=<a href='/topic/show?id=9f233e69666' target=_blank style='color:#2F92EE;'>#反复咳血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37696, encryptionId=9f233e69666, topicName=反复咳血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Oct 20 12:45:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680065, encodeId=c617168006573, content=<a href='/topic/show?id=67e282e66d8' target=_blank style='color:#2F92EE;'>#肿物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82766, encryptionId=67e282e66d8, topicName=肿物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=179b27837900, createdName=LSJ120, createdTime=Mon May 14 11:45:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278304, encodeId=1b682e8304fa, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jan 14 06:46:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277989, encodeId=49a12e7989dc, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Sat Jan 13 05:37:33 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277485, encodeId=24ae2e748594, content=受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/11/843340fb4682f03b12c0770c09229692.jpg, createdBy=47aa2244654, createdName=121503aam61暂无昵称, createdTime=Thu Jan 11 09:29:53 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277461, encodeId=fcd32e746156, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Jan 11 08:27:55 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277413, encodeId=0e512e741313, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Jan 11 06:54:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277395, encodeId=f1822e739514, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Jan 11 06:42:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277378, encodeId=e4482e737887, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Jan 11 05:21:04 CST 2018, time=2018-01-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1892130, encodeId=b9c71892130f5, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Fri Sep 21 18:45:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989752, encodeId=f6601989e528a, content=<a href='/topic/show?id=9f233e69666' target=_blank style='color:#2F92EE;'>#反复咳血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37696, encryptionId=9f233e69666, topicName=反复咳血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Oct 20 12:45:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680065, encodeId=c617168006573, content=<a href='/topic/show?id=67e282e66d8' target=_blank style='color:#2F92EE;'>#肿物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82766, encryptionId=67e282e66d8, topicName=肿物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=179b27837900, createdName=LSJ120, createdTime=Mon May 14 11:45:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278304, encodeId=1b682e8304fa, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jan 14 06:46:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277989, encodeId=49a12e7989dc, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Sat Jan 13 05:37:33 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277485, encodeId=24ae2e748594, content=受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/11/843340fb4682f03b12c0770c09229692.jpg, createdBy=47aa2244654, createdName=121503aam61暂无昵称, createdTime=Thu Jan 11 09:29:53 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277461, encodeId=fcd32e746156, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Jan 11 08:27:55 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277413, encodeId=0e512e741313, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Jan 11 06:54:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277395, encodeId=f1822e739514, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Jan 11 06:42:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277378, encodeId=e4482e737887, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Jan 11 05:21:04 CST 2018, time=2018-01-11, status=1, ipAttribution=)]
    2018-05-14 LSJ120
  4. [GetPortalCommentsPageByObjectIdResponse(id=1892130, encodeId=b9c71892130f5, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Fri Sep 21 18:45:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989752, encodeId=f6601989e528a, content=<a href='/topic/show?id=9f233e69666' target=_blank style='color:#2F92EE;'>#反复咳血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37696, encryptionId=9f233e69666, topicName=反复咳血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Oct 20 12:45:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680065, encodeId=c617168006573, content=<a href='/topic/show?id=67e282e66d8' target=_blank style='color:#2F92EE;'>#肿物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82766, encryptionId=67e282e66d8, topicName=肿物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=179b27837900, createdName=LSJ120, createdTime=Mon May 14 11:45:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278304, encodeId=1b682e8304fa, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jan 14 06:46:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277989, encodeId=49a12e7989dc, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Sat Jan 13 05:37:33 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277485, encodeId=24ae2e748594, content=受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/11/843340fb4682f03b12c0770c09229692.jpg, createdBy=47aa2244654, createdName=121503aam61暂无昵称, createdTime=Thu Jan 11 09:29:53 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277461, encodeId=fcd32e746156, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Jan 11 08:27:55 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277413, encodeId=0e512e741313, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Jan 11 06:54:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277395, encodeId=f1822e739514, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Jan 11 06:42:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277378, encodeId=e4482e737887, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Jan 11 05:21:04 CST 2018, time=2018-01-11, status=1, ipAttribution=)]
    2018-01-14 txqjm

    谢谢了.学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1892130, encodeId=b9c71892130f5, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Fri Sep 21 18:45:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989752, encodeId=f6601989e528a, content=<a href='/topic/show?id=9f233e69666' target=_blank style='color:#2F92EE;'>#反复咳血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37696, encryptionId=9f233e69666, topicName=反复咳血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Oct 20 12:45:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680065, encodeId=c617168006573, content=<a href='/topic/show?id=67e282e66d8' target=_blank style='color:#2F92EE;'>#肿物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82766, encryptionId=67e282e66d8, topicName=肿物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=179b27837900, createdName=LSJ120, createdTime=Mon May 14 11:45:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278304, encodeId=1b682e8304fa, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jan 14 06:46:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277989, encodeId=49a12e7989dc, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Sat Jan 13 05:37:33 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277485, encodeId=24ae2e748594, content=受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/11/843340fb4682f03b12c0770c09229692.jpg, createdBy=47aa2244654, createdName=121503aam61暂无昵称, createdTime=Thu Jan 11 09:29:53 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277461, encodeId=fcd32e746156, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Jan 11 08:27:55 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277413, encodeId=0e512e741313, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Jan 11 06:54:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277395, encodeId=f1822e739514, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Jan 11 06:42:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277378, encodeId=e4482e737887, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Jan 11 05:21:04 CST 2018, time=2018-01-11, status=1, ipAttribution=)]
    2018-01-13 lou.minghong

    学习谢谢分享!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1892130, encodeId=b9c71892130f5, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Fri Sep 21 18:45:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989752, encodeId=f6601989e528a, content=<a href='/topic/show?id=9f233e69666' target=_blank style='color:#2F92EE;'>#反复咳血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37696, encryptionId=9f233e69666, topicName=反复咳血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Oct 20 12:45:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680065, encodeId=c617168006573, content=<a href='/topic/show?id=67e282e66d8' target=_blank style='color:#2F92EE;'>#肿物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82766, encryptionId=67e282e66d8, topicName=肿物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=179b27837900, createdName=LSJ120, createdTime=Mon May 14 11:45:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278304, encodeId=1b682e8304fa, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jan 14 06:46:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277989, encodeId=49a12e7989dc, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Sat Jan 13 05:37:33 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277485, encodeId=24ae2e748594, content=受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/11/843340fb4682f03b12c0770c09229692.jpg, createdBy=47aa2244654, createdName=121503aam61暂无昵称, createdTime=Thu Jan 11 09:29:53 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277461, encodeId=fcd32e746156, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Jan 11 08:27:55 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277413, encodeId=0e512e741313, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Jan 11 06:54:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277395, encodeId=f1822e739514, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Jan 11 06:42:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277378, encodeId=e4482e737887, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Jan 11 05:21:04 CST 2018, time=2018-01-11, status=1, ipAttribution=)]
    2018-01-11 121503aam61暂无昵称

    受益

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1892130, encodeId=b9c71892130f5, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Fri Sep 21 18:45:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989752, encodeId=f6601989e528a, content=<a href='/topic/show?id=9f233e69666' target=_blank style='color:#2F92EE;'>#反复咳血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37696, encryptionId=9f233e69666, topicName=反复咳血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Oct 20 12:45:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680065, encodeId=c617168006573, content=<a href='/topic/show?id=67e282e66d8' target=_blank style='color:#2F92EE;'>#肿物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82766, encryptionId=67e282e66d8, topicName=肿物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=179b27837900, createdName=LSJ120, createdTime=Mon May 14 11:45:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278304, encodeId=1b682e8304fa, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jan 14 06:46:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277989, encodeId=49a12e7989dc, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Sat Jan 13 05:37:33 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277485, encodeId=24ae2e748594, content=受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/11/843340fb4682f03b12c0770c09229692.jpg, createdBy=47aa2244654, createdName=121503aam61暂无昵称, createdTime=Thu Jan 11 09:29:53 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277461, encodeId=fcd32e746156, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Jan 11 08:27:55 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277413, encodeId=0e512e741313, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Jan 11 06:54:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277395, encodeId=f1822e739514, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Jan 11 06:42:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277378, encodeId=e4482e737887, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Jan 11 05:21:04 CST 2018, time=2018-01-11, status=1, ipAttribution=)]
    2018-01-11 Y—xianghai

    学习了新知识

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1892130, encodeId=b9c71892130f5, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Fri Sep 21 18:45:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989752, encodeId=f6601989e528a, content=<a href='/topic/show?id=9f233e69666' target=_blank style='color:#2F92EE;'>#反复咳血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37696, encryptionId=9f233e69666, topicName=反复咳血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Oct 20 12:45:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680065, encodeId=c617168006573, content=<a href='/topic/show?id=67e282e66d8' target=_blank style='color:#2F92EE;'>#肿物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82766, encryptionId=67e282e66d8, topicName=肿物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=179b27837900, createdName=LSJ120, createdTime=Mon May 14 11:45:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278304, encodeId=1b682e8304fa, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jan 14 06:46:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277989, encodeId=49a12e7989dc, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Sat Jan 13 05:37:33 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277485, encodeId=24ae2e748594, content=受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/11/843340fb4682f03b12c0770c09229692.jpg, createdBy=47aa2244654, createdName=121503aam61暂无昵称, createdTime=Thu Jan 11 09:29:53 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277461, encodeId=fcd32e746156, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Jan 11 08:27:55 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277413, encodeId=0e512e741313, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Jan 11 06:54:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277395, encodeId=f1822e739514, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Jan 11 06:42:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277378, encodeId=e4482e737887, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Jan 11 05:21:04 CST 2018, time=2018-01-11, status=1, ipAttribution=)]
    2018-01-11 txqjm

    谢谢了.学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1892130, encodeId=b9c71892130f5, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Fri Sep 21 18:45:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989752, encodeId=f6601989e528a, content=<a href='/topic/show?id=9f233e69666' target=_blank style='color:#2F92EE;'>#反复咳血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37696, encryptionId=9f233e69666, topicName=反复咳血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Oct 20 12:45:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680065, encodeId=c617168006573, content=<a href='/topic/show?id=67e282e66d8' target=_blank style='color:#2F92EE;'>#肿物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82766, encryptionId=67e282e66d8, topicName=肿物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=179b27837900, createdName=LSJ120, createdTime=Mon May 14 11:45:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278304, encodeId=1b682e8304fa, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jan 14 06:46:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277989, encodeId=49a12e7989dc, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Sat Jan 13 05:37:33 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277485, encodeId=24ae2e748594, content=受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/11/843340fb4682f03b12c0770c09229692.jpg, createdBy=47aa2244654, createdName=121503aam61暂无昵称, createdTime=Thu Jan 11 09:29:53 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277461, encodeId=fcd32e746156, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Jan 11 08:27:55 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277413, encodeId=0e512e741313, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Jan 11 06:54:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277395, encodeId=f1822e739514, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Jan 11 06:42:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277378, encodeId=e4482e737887, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Jan 11 05:21:04 CST 2018, time=2018-01-11, status=1, ipAttribution=)]
    2018-01-11 1dd8c52fm63(暂无匿称)

    了解了解.学习学习

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1892130, encodeId=b9c71892130f5, content=<a href='/topic/show?id=1b445e1232d' target=_blank style='color:#2F92EE;'>#支气管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57123, encryptionId=1b445e1232d, topicName=支气管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f503121, createdName=zjubiostat, createdTime=Fri Sep 21 18:45:00 CST 2018, time=2018-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1989752, encodeId=f6601989e528a, content=<a href='/topic/show?id=9f233e69666' target=_blank style='color:#2F92EE;'>#反复咳血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37696, encryptionId=9f233e69666, topicName=反复咳血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Oct 20 12:45:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1680065, encodeId=c617168006573, content=<a href='/topic/show?id=67e282e66d8' target=_blank style='color:#2F92EE;'>#肿物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82766, encryptionId=67e282e66d8, topicName=肿物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=179b27837900, createdName=LSJ120, createdTime=Mon May 14 11:45:00 CST 2018, time=2018-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278304, encodeId=1b682e8304fa, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Sun Jan 14 06:46:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277989, encodeId=49a12e7989dc, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Sat Jan 13 05:37:33 CST 2018, time=2018-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277485, encodeId=24ae2e748594, content=受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/11/843340fb4682f03b12c0770c09229692.jpg, createdBy=47aa2244654, createdName=121503aam61暂无昵称, createdTime=Thu Jan 11 09:29:53 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277461, encodeId=fcd32e746156, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Thu Jan 11 08:27:55 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277413, encodeId=0e512e741313, content=谢谢了.学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Thu Jan 11 06:54:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277395, encodeId=f1822e739514, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Jan 11 06:42:47 CST 2018, time=2018-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277378, encodeId=e4482e737887, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu Jan 11 05:21:04 CST 2018, time=2018-01-11, status=1, ipAttribution=)]
    2018-01-11 yjs木玉

    好好好好好好好好

    0

相关资讯

关于公布2017年度医学科学领域专业评审组组成名单的公告

2017年7月21日至2017年7月25日,医学科学部组织评审:面上项目、青年科学基金项目、地区科学基金项目。 根据相关规定,现发布评审会专家评审组组成名单(按姓氏拼音顺序排列):白钢  白晓春  毕宏生  毕宇芳  步宏  蔡绍曦  曹彬  曹建平  曾芳  

Research Policy:读博不易!约1/3博士生面临或者潜伏有精神问题

“大约1/3的在读博士存在或者潜伏有包括抑郁症在内的精神障碍!”这是近期发表于《Research Policy》期刊上的一篇学术论文的研究结果。虽然这一结论统计自小样本——就读于比利时佛兰德大学的3659名博士生(其中90%的博士生攻读科学和社会科学专业),但是它无疑再一次重申了学术界的精神健康问题。1、51%的博士心理压力大科研竞争压力大、论文发表不易、生活作息不规律、收入待遇不高……诸如此类的

《自然》列出2018值得期待科学事件

新一年科学界有什么值得我们关注的事情?从各国耗资巨大的太空任务到基因编辑,英国《自然》杂志2日选出了多项可能在2018年会给科学界带来影响的事件。

算命先生PK妇产医生,最后受伤的会是谁?

前几日,妇产科李玲医生便遇到了这么一位产妇。她来的时候已经出现规律宫缩,宫口已开0.5公分,像这种头胎剖宫产、且有宫缩的情况,李玲医生建议尽快进行手术,不然等到宫缩严重时,必须在5分钟内打开子宫(但医院不具备这样的条件),否则产妇的瘢痕子宫有可能会引起子宫破裂等一系列危险症状。

为什么总是觉得冷?科学来拯救你!

在办公室里,或者在聚会中,如果你的同事或朋友感觉舒适甚至是有点儿热时,而你却手脚冰凉甚至微微发抖,那么这说明你的内部恒温系统出现问题了。医学上称之为“寒冷不耐受”。以下是一些解释你为什么感觉寒冷的原因,以及一些可以改善这种状况的方法。脂肪不足说白了,就是太瘦了!甘油三酯、胆固醇以及其他必要的脂肪酸(指的是身体无法自身合成的脂肪)能够存储能量并且保护我们的器官。脂肪还能够包裹身体,所以体重不足的人比

樊代明:科学非黑即白 医学却有无数结果

世界医学发展过去如何?明天怎么办?仁者见仁,智者见智。剑桥大学的路易·普尔教授说过,人从来没有活得像今天这么长,也从来没有像今天这么健康,但是医学受到的质疑也没有像今天这么激烈。甚至有时候病人把医生杀了。“我们要活得更加健康,活得更长,但是现代医学光治病,这种办法可能让它走到了瓶颈状态。”中国工程院院士樊代明在第二届中国家庭健康大会上说到。健康大数据第二批试点受各界热捧12月8日,中央政治局第二次